These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27153945)

  • 1. Steroids in fluid and/or vasoactive infusion dependent pediatric shock: study protocol for a randomized controlled trial.
    O'Hearn K; McNally D; Choong K; Acharya A; Wong HR; Lawson M; Ramsay T; McIntyre L; Gilfoyle E; Tucci M; Wensley D; Gottesman R; Morrison G; Menon K;
    Trials; 2016 May; 17(1):238. PubMed ID: 27153945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A trial to determine whether septic shock-reversal is quicker in pediatric patients randomized to an early goal-directed fluid-sparing strategy versus usual care (SQUEEZE): study protocol for a pilot randomized controlled trial.
    Parker MJ; Thabane L; Fox-Robichaud A; Liaw P; Choong K;
    Trials; 2016 Nov; 17(1):556. PubMed ID: 27876084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of stated physician practices and beliefs on the use of steroids in pediatric fluid and/or vasoactive infusion-dependent shock.
    Menon K; McNally JD; Choong K; Ward RE; Lawson ML; Ramsay T; Wong HR
    Pediatr Crit Care Med; 2013 Jun; 14(5):462-6. PubMed ID: 23628832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted tissue perfusion versus macrocirculation-guided standard care in patients with septic shock (TARTARE-2S): study protocol and statistical analysis plan for a randomized controlled trial.
    Pettilä V; Merz T; Wilkman E; Perner A; Karlsson S; Lange T; Hästbacka J; Hjortrup PB; Kuitunen A; Jakob SM; Takala J
    Trials; 2016 Aug; 17():384. PubMed ID: 27484695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized Controlled Trial of Corticosteroids in Pediatric Septic Shock: A Pilot Feasibility Study.
    Menon K; McNally D; O'Hearn K; Acharya A; Wong HR; Lawson M; Ramsay T; McIntyre L; Gilfoyle E; Tucci M; Wensley D; Gottesman R; Morrison G; Choong K;
    Pediatr Crit Care Med; 2017 Jun; 18(6):505-512. PubMed ID: 28406862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. REstricted Fluid REsuscitation in Sepsis-associated Hypotension (REFRESH): study protocol for a pilot randomised controlled trial.
    Macdonald SPJ; Taylor DM; Keijzers G; Arendts G; Fatovich DM; Kinnear FB; Brown SGA; Bellomo R; Burrows S; Fraser JF; Litton E; Ascencio-Lane JC; Anstey M; McCutcheon D; Smart L; Vlad I; Winearls J; Wibrow B
    Trials; 2017 Aug; 18(1):399. PubMed ID: 28851407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early initiation of low-dose hydrocortisone treatment for septic shock in adults: A randomized clinical trial.
    Lv QQ; Gu XH; Chen QH; Yu JQ; Zheng RQ
    Am J Emerg Med; 2017 Dec; 35(12):1810-1814. PubMed ID: 28615145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose hydrocortisone in pediatric septic shock: an exploratory study in a third world setting.
    Valoor HT; Singhi S; Jayashree M
    Pediatr Crit Care Med; 2009 Jan; 10(1):121-5. PubMed ID: 19057445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abdominal Septic Shock - Endotoxin Adsorption Treatment (ASSET) - endotoxin removal in abdominal and urogenital septic shock with the Alteco® LPS Adsorber: study protocol for a double-blinded, randomized placebo-controlled trial.
    Lipcsey M; Tenhunen J; Sjölin J; Frithiof R; Bendel S; Flaatten H; Kawati R; Kuitunen A; Tønnessen TI; Rubertsson S
    Trials; 2016 Dec; 17(1):587. PubMed ID: 27931259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Survey of Attitudes and Practices Regarding the Use of Steroid Supplementation in Pediatric Sepsis.
    Carmean A; Fortenberry JD; McCracken C; Hebbar KB
    Pediatr Emerg Care; 2015 Oct; 31(10):694-8. PubMed ID: 26414641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.
    Russell JA; Walley KR; Gordon AC; Cooper DJ; Hébert PC; Singer J; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ;
    Crit Care Med; 2009 Mar; 37(3):811-8. PubMed ID: 19237882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroid therapy in refractory shock following cardiac arrest: a randomized, double-blind, placebo-controlled, trial.
    Donnino MW; Andersen LW; Berg KM; Chase M; Sherwin R; Smithline H; Carney E; Ngo L; Patel PV; Liu X; Cutlip D; Zimetbaum P; Cocchi MN;
    Crit Care; 2016 Apr; 20():82. PubMed ID: 27038920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-Blind Randomized Clinical Trial Comparing Dopamine and Epinephrine in Pediatric Fluid-Refractory Hypotensive Septic Shock.
    Ramaswamy KN; Singhi S; Jayashree M; Bansal A; Nallasamy K
    Pediatr Crit Care Med; 2016 Nov; 17(11):e502-e512. PubMed ID: 27673385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial.
    Hager DN; Hooper MH; Bernard GR; Busse LW; Ely EW; Fowler AA; Gaieski DF; Hall A; Hinson JS; Jackson JC; Kelen GD; Levine M; Lindsell CJ; Malone RE; McGlothlin A; Rothman RE; Viele K; Wright DW; Sevransky JE; Martin GS
    Trials; 2019 Apr; 20(1):197. PubMed ID: 30953543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-Blind Prospective Randomized Controlled Trial of Dopamine Versus Epinephrine as First-Line Vasoactive Drugs in Pediatric Septic Shock.
    Ventura AM; Shieh HH; Bousso A; Góes PF; de Cássia F O Fernandes I; de Souza DC; Paulo RL; Chagas F; Gilio AE
    Crit Care Med; 2015 Nov; 43(11):2292-302. PubMed ID: 26323041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Fluid Minimization Following Initial Resuscitation in Septic Shock: A Pilot Study.
    Chen C; Kollef MH
    Chest; 2015 Dec; 148(6):1462-1469. PubMed ID: 26291900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluid resuscitation in the management of early septic shock (FINESS): a randomized controlled feasibility trial.
    McIntyre LA; Fergusson D; Cook DJ; Rankin N; Dhingra V; Granton J; Magder S; Stiell I; Taljaard M; Hebert PC;
    Can J Anaesth; 2008 Dec; 55(12):819-26. PubMed ID: 19050085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive use of physostigmine salicylate (Anticholium®) in perioperative sepsis and septic shock: study protocol for a randomized, double-blind, placebo-controlled, monocentric trial (Anticholium® per Se).
    Zimmermann JB; Pinder N; Bruckner T; Lehmann M; Motsch J; Brenner T; Hoppe-Tichy T; Swoboda S; Weigand MA; Hofer S
    Trials; 2017 Nov; 18(1):530. PubMed ID: 29126416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Increasing Hydrocortisone to 300 mg Per Day in the Treatment of Septic Shock: a Pilot Study.
    Hyvernat H; Barel R; Gentilhomme A; Césari-Giordani JF; Freche A; Kaidomar M; Goubaux B; Pradier C; Dellamonica J; Bernardin G
    Shock; 2016 Nov; 46(5):498-505. PubMed ID: 27405061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis: The PRoMPT BOLUS Randomized Controlled Trial Pilot Feasibility Study.
    Balamuth F; Kittick M; McBride P; Woodford AL; Vestal N; Casper TC; Metheney M; Smith K; Atkin NJ; Baren JM; Dean JM; Kuppermann N; Weiss SL
    Acad Emerg Med; 2019 Dec; 26(12):1346-1356. PubMed ID: 31183919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.